Stöhr R - Search Results

1

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.

Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Szczyrba J, et al. Among authors: stohr r. Mol Cancer Res. 2011 Jun;9(6):791-800. doi: 10.1158/1541-7786.MCR-10-0573. Epub 2011 May 18. Mol Cancer Res. 2011. PMID: 21593139

2

[Precancerous conditions in the urothelium. Early detection and molecular understanding through endoscopic fluorescence diagnosis].

Knüchel R, Hartmann A, Stöhr R, Baumgartner R, Zaak D, Krieg RC. Knüchel R, et al. Among authors: stohr r. Pathologe. 2003 Oct;24(6):473-9. doi: 10.1007/s00292-003-0651-8. Pathologe. 2003. PMID: 14605854 German.

3

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.

Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger H, Essers L, Weber B, Hermann K, Rosenthal A, Hartmann A, Dahl E. Klopocki E, et al. Among authors: stohr r. Int J Oncol. 2004 Sep;25(3):641-9. Int J Oncol. 2004. PMID: 15289865

4

[Plasmacytoid carcinoma. Five case reports of a rare variant of urothelial carcinoma].

Keck B, Stöhr R, Goebell PJ, Fritsche HM, Wullich B, Hartmann A. Keck B, et al. Among authors: stohr r. Pathologe. 2008 Sep;29(5):379-82. doi: 10.1007/s00292-008-1017-z. Pathologe. 2008. PMID: 18600326 German.

5

[EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer].

Nawroth R, Stöhr R, Hartmann A, Gschwend JE, Retz M. Nawroth R, et al. Among authors: stohr r. Urologe A. 2008 Sep;47(9):1152-6. doi: 10.1007/s00120-008-1828-9. Urologe A. 2008. PMID: 18688595 German.

6

The microRNA profile of prostate carcinoma obtained by deep sequencing.

Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. Szczyrba J, et al. Among authors: stohr r. Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30. Mol Cancer Res. 2010. PMID: 20353999

7

[EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].

Nawroth R, Hartmann A, Wild P, Lehmann J, Stöhr R, Gschwend JE, Retz M. Nawroth R, et al. Among authors: stohr r. Pathologe. 2010 Oct;31 Suppl 2:251-4. doi: 10.1007/s00292-010-1328-8. Pathologe. 2010. PMID: 20661575 German.

8

Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.

Greiner M, Kreutzer B, Jung V, Grobholz R, Hasenfus A, Stöhr RF, Tornillo L, Dudek J, Stöckle M, Unteregger G, Kamradt J, Wullich B, Zimmermann R. Greiner M, et al. Among authors: stohr rf. Int J Cancer. 2011 May 15;128(10):2284-95. doi: 10.1002/ijc.25580. Int J Cancer. 2011. PMID: 20669223

9

MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.

Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, Danenberg PV, Stöhr R, Stöckle M, Lehmann J, Schuler M, Hartmann A. Hoffmann AC, et al. Among authors: stohr r. Neoplasia. 2010 Aug;12(8):628-36. doi: 10.1593/neo.10402. Neoplasia. 2010. PMID: 20689757 Free PMC article. Clinical Trial.

10

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.

Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B. Wach S, et al. Among authors: stohr r. Int J Cancer. 2012 Feb 1;130(3):611-21. doi: 10.1002/ijc.26064. Epub 2011 May 9. Int J Cancer. 2012. PMID: 21400514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters